The ppar activator docosahexaenoic acid prevents acetaminophen hepatotoxicity in male cd-1 mice

Journal of Toxicology and Environmental Health - Part A

Volumn 58, Issue 3, 1999, Pages 171-186

  Nguyen, Kim A ^a   Carbone, John M ^a   Silva, Vanessa M ^a   Chen, Chuan ^a   Hennig, Gayle E ^a   Whiteley, Herbert E ^a   Manautou, José E ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFIBRATE; CORN OIL; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; GLUTATHIONE; IDITOL DEHYDROGENASE; PALMITOYL COENZYME A; PARACETAMOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCURONIDATION; HISTOLOGY; LIVER MICROSOME; LIVER NECROSIS; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TISSUE DEGENERATION;

ACETAMINOPHEN; ALKANE 1-MONOOXYGENASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOTRANSFORMATION; BLOTTING, WESTERN; CLOFIBRATE; CYTOCHROME P-450 ENZYME SYSTEM; DOCOSAHEXAENOIC ACIDS; GLUCURONATES; HEPATITIS, TOXIC; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED STRAINS; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; ORGAN SIZE; PALMITOYL COENZYME A; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SUCCINATE DEHYDROGENASE; SULFHYDRYL COMPOUNDS; TRANSCRIPTION FACTORS;

ANIMALIA; ZEA MAYS;

EID: 0033570236     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/009841099157377     Document Type: Article

References (35)

1. Bartolone, J. B., Beierschmitt, W. P., Birge, R. B., Emeigh Hart, S. G., Wyand, D. S., Cohen, S. D., Khairallah, E. A. 1989. Selective acetaminophen metabolite binding to extrahepatic proteins: An in vivo and in vitro analysis. Toxicol. Appl. Pharmacol.99:240-249.
2. Beierschmitt, W. P., Brady, J. T., Bartolone, J. B., Wyand, D. S., Khairallah, E. A., and Cohen, S. D. 1989. Selective protein arylation and age dependency of acetaminophen hepatotoxicity in mice. Toxicol. Appl. Pharmacol.98:517-529.
3. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem.72:248-254.
4. Buckpitt, A. R., Rollins, D. E., Nelson, S. D., Franklin, R. B., and Mitchell, J. R. 1977. Quantitative determination of the glutathione, cysteine, and N-acetyl cysteine conjugates of acetaminophen by high-pressure l iquid chromatography. Anal. Biochem.83:168-177.
5. Dahlin, D. C., Miwa, G. T., Lu, A. Y., and Nelson, S. D. 1984. N-Acetyl-p-benzoquinoneimine: A cytochrome P-450 mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA81:1327-1331.
6. Dannenberg, A. J., and Yang, E. K. 1992. Effect of dietary lipids on levels of UDP-glucuronosyltrans-ferase activity in liver. Biochem. Pharmacol.44:335-340.
7. Drevon, C. A. 1992. Marine oils and their effects. Nutr. Rev.50:38-45.
8. Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys.82:70-77.
9. Emeigh Hart, S. G., Beierschmitt, W. P., Wyand, S. D., Khairallah, E. A., Cohen, S. D. 1994. Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol. Appl. Pharmacol.126:267-275.
10. Gerlach, U., and Hiby, W. 1974. Sorbitol dehydrogenase. In Methods in enzymatic analysis, ed. H. U. Bergmeyer, 2nd ed., pp. 569-573. Weinheim: Verlag Chemie.
11. Gonzalez, F. J., Fernandez-Salguero, P., Lee, S. S. T., Pineau, T., and Ward, J. M. 1995. Xenobiotic receptor knockout mice. Toxicol. Lett.82/83:117-121.
12. Gottlicher, M., Demoz, A., Svensson, D., Tollet, P., Berge, R. K., and Gustafsson, J.-A. 1993. Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem. Pharmacol.46:2177-2184.
13. Hazelton, G. A., Hjelle, J. J., and Klaassen, C. D. 1985. Effect of butylated hydroxyanisole on hepatic glucuronidation capacity i n mice. Toxicol. Appl. Pharmacol.78:280-290.
14. Howie, D., Adriaenssens, P., and Prescott, L. F. 1977. Paracetamol metabolism following overdose: Application of high performance l iquid chromatography. J. Pharm. Pharmacol.29:235-237.
15. Issemann, I., and Green, S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature347:645-650.
16. Kuralay, F., Akarca, U. S., Ozutemiz, A. O., Kutay, F., and Batur, Y. 1998. Possible role of glutathione in prevention of acetaminophen-induced hepatotoxicity enhanced by fish oil in male Wistar rats. J. Toxicol. Environ. Health53:223-229.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head bacteriophage T4. Nature227:680-685.
18. Lazarow, P. B. 1981. Assay of peroxisomal p-oxidation of fatty acids. Methods Enzymol. 72:315-319.
19. Lee, S. S. T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. 1995. Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol.15:3012-3022.
20. Manautou, J. E., and Carlson, G. P. 1992. Comparison of pulmonary and hepatic glucuronidation and sulphation of ethanol in rat and rabbit in vitro. Xenobiotica22:1309-1319.
21. Manautou, J. E., Emeight Hart, S. G., Khairallah, E. A., and Cohen, S. D. 1995. Protection against acetaminophen hepatotoxicity by a single dose of clofibrate: Effects on selective protein aryla-tion and glutathione depletion. Fundam. Appl. Toxicol.29:229-237.
22. Manautou, J. E., Hoivik, D. J., Tveit, A., Emeigh Hart, S. G., Khairallah, E. A., and Cohen, S. D. 1994. Clofibrate pretreatment diminishes acetaminophen's selective covalent binding and hepatotoxicity. Toxicol. Appl. Pharmacol.129:252-263.
23. Manautou, J. E., Tveit, A., Hoivik, D. J., Khairallah, E. A., Cohen, S. D. 1996. Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase i n biliary concentration of acetaminophen-glutathione adducts. Toxicol. Appl. Pharmacol.140:3038.
24. Manautou, J. E., Silva, V. M., Hennig, G. E., and Whiteley, H. E. 1998. Repeated dosing with the peroxisome proliferator clofibrate decreases the toxicity of model hepatotoxic agents in male mice. Toxicology172:1-10.
25. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. 1973a. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187:185-194.
26. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., and Brodie, B. B. 1973b. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther.187:211-217.
27. Moody, D. E., Gibson, G. G., Grant, D. F., Magdalou, J., and Rao, M. S. 1992. Peroxisome pro l ifera-tors, a unique set of drug-metabolizing enzyme inducers: Commentary on a symposium. Drug Metab. Dispos.20:779-791.
28. Nicholls-Grzemski, F. A., Calder, I. C., and Priestly, B. G. 1992. Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. Biochem. Pharmacol.43:1395-1396.
29. Padley, F. B., Gunstone, F. D., and Harwood, J. L. 1994. Marine oils: fish and whale oils. In The lipid handbook, eds. F. D. Gunstone, J. L. Harwood, and F. B. Padley, 2nd ed., pp. 167-183. London: Chapman and Hall.
30. Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J., and Jump, D. B. 1997. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S1 4 gene expression does not require peroxisome proliferator activated receptor-a. J. Biol. Chem.272:26827-25832.
31. Schoonjans, K., Staels, B., and Auwerx, J. 1996. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925.
32. Sorensen, H. N., Treuter, E., and Gustafsson, J.-A. 1998. Regulation of peroxisome proliferator-acti-vated receptors. Vitam. Horm.54:121-165.
33. Speck, R. F., and Lauterburg, B. H. 1991. Fish oil protects mice against acetaminophen hepatotoxicity in vivo. Hepatology13:557-561.
34. Willson, T. M., and Wahli, W. 1997. Peroxisome proliferator-activated receptor agonists. Curr. Opin. Chem. Biol.1:235-241.
35. Willumsen, N., Hexeberg, S., Skorve, J., Lundquist, M., and Berge, R. K. 1992. Docosahexaenoic acid shows no triglyceride lowering effect but increases the peroxisomal fatty acid oxidation in liver of rats. J. Lipid Res.34:13-22.